Corrected Results Press Release
Natco Pharma Ltd has submitted to BSE a copy of Corrected Results Press Release for the period ended December 31, 2013.14-02-2014
14-02-2014
Fixes Record Date for Interim Dividend
Natco Pharma Ltd has informed BSE that February 25, 2014 has been fixed as the Record Date for the purpose of payment of Interim Dividend. The said interim dividend pay-by-date is March 06, 2014.13-02-2014
Limited Review for Dec 31, 2013
Natco Pharma Ltd has submitted to BSE a Copy of the Limited Review Report for the period ended December 31, 2013.13-02-2014
Results Press Release
Natco Pharma Ltd has submitted to BSE a copy of Results Press Release for the period ended December 31, 2013.13-02-2014
Board declares Interim Dividend
Natco Pharma Ltd has informed BSE that the Board of Directors of the Company at its meeting held on February 13, 2014, inter alia, has considered and approved the following:1. The Board also recommended payment of an interim dividend of Rs. 5/- per equity share of Rs. 10/- each for the year 2013-2014.2. Mr. Vivek Chhacchi, Nominee Director of CX Securities Ltd. and Mr. D. G. Prasad, Independent Director inducted as Additional...13-02-2014
Financial Results for Dec 31, 2013
Natco Pharma Ltd has informed BSE about the Financial Results for the period ended December 31, 2013.13-02-2014
Board to consider Interim Dividend
Natco Pharma Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on February 13, 2014, inter alia, to consider the unaudited financial Results for the quarter ended December 31, 2013, to consider Interim Dividend, if any, for the financial year 2013-14 and related matters etc.03-02-2014
Updates on Financial Results for Sept 30, 2013
Natco Pharma Ltd has submitted to BSE a copy of updated Financial Results for the period ended Sept 30, 2013.30-12-2013
Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011
Citibank N A has submitted the disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 201102-12-2013
Allotment of Equity shares on Preferential Basis
Natco Pharma Ltd has informed BSE that a duly constituted Committee of Directors, at a meeting held on November 29, 2013 allotted 17,00,000 equity shares of Rs. 10/- each at a premium of Rs. 628.40 per share on a Preferential basis to M/s. CX Securities Limited, Mauritius.29-11-2013